Retrospective analysis of steroid therapy for radiation-induced lung injury in lung cancer patients

Ikuo Sekine(University of Tsukuba), Tomohide Tamura(St. Luke's International Hospital), Minako Sumi(Tokyo Metropolitan Geriatric Hospital), Tetsuro Kodama, Yuichiro Ohe(National Cancer Center), Yoshinori Ito(National Cancer Center Hospital East), Hideo Kunitoh(Japanese Red Cross Medical Center), Hiroshi Nokihara(Tokushima University Hospital), Nagahiro Saijo(National Cancer Center Hospital East), Noboru Yamamoto(Tokyo National Hospital)
Radiotherapy and Oncology
July 1, 2006
10.1016/j.radonc.2006.06.007
Cited by 68

Related Papers

Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
|New England Journal of Medicine|2009|8.2k
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
|Journal of Thoracic Oncology|2011|4.8k
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2017|2.5k
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2019|2k
Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients With Advanced Non–Small-Cell Lung Cancer in Asia (IPASS)
|Journal of Clinical Oncology|2011|1.6k